Changhai Hospital
Clinical trials sponsored by Changhai Hospital, explained in plain language.
-
New drug combo aims to save bladders in High-Risk cancer patients
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (toripalimab) to standard BCG treatment can help prevent bladder cancer from coming back after surgery. It involves 31 adults with high-risk non-muscle-invasive bladder cancer who have not had BCG before. The goal is to see if…
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Engineered immune cells take on tough pancreatic cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced pancreatic cancer whose tumors have a specific genetic change (KRAS G12V) and a certain immune type (HLA-A*11:01). The treatment uses the patient's own immune cells, modified in a lab to recognize and attack cancer cells. …
Phase: PHASE1, PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
Fluid combo may stop pancreatitis after stone blasting
Prevention Recruiting nowThis study tests whether giving extra fluids through a vein along with a standard anti-inflammatory drug (indometacin) can better prevent pancreatitis after a procedure that uses shock waves to break up pancreatic stones. About 1,250 adults with painful chronic pancreatitis will …
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated May 04, 2026 16:17 UTC